Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Effets de la stimulation Theta Burst sur le cerveau, le comportement et les symptômes cliniques chez les adultes atteints de trouble bipolaire

13 octobre 2026 mis à jour par: Mary Phillips, MD MD (Cantab)

Élucider les mécanismes neuronaux de l'hypo/manie à l'aide de la stimulation Theta Burst

Bipolar Disorder (BD) is a common and highly debilitating psychiatric disorder, however, the predisposing brain mechanisms are poorly understood. Here, the investigators aim to examine the immediate effect of transcranial brain stimulation (TBS) on brain activity and emotions in adults with and without BD as a first stage toward understanding the predisposing brain mechanisms of BD. The investigators hypothesize that TBS will reduce brain activity while playing a game with rewards in all adults, but the TBS will reduce brain activity more in the adults with BD compared to adults without BD. Furthermore, the investigators hypothesize that this reduced brain activity will be associated with reduced BD symptoms, such as negative emotions.

Aperçu de l'étude

Statut

Complété

Les conditions

Intervention / Traitement

Description détaillée

This study aims to examine the effects of noninvasive stimulation on brain activity as measured by functional magnetic resonance imaging (fMRI) in participants with and without Bipolar I Disorder. Eligible participants will undergo 5 study visits: a screening visit, a baseline MRI visit, and 3 cTBS visits. Participants will receive brain stimulation and undergo fMRI scanning at each of the 3 cTBS study visits, however, at one of the visits, the brain stimulation will be a sham. The research associates and participants will be blinded to when the sham occurs, which will be randomized beforehand. Certain information is withheld to protect the scientific integrity of the study design

Type d'étude

Interventionnel

Inscription (Réel)

146

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

    • Pennsylvania
      • Pittsburgh, Pennsylvania, États-Unis, 15213
        • University of Pittsburgh

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

18 ans à 35 ans (Adulte)

Accepte les volontaires sains

Oui

Sexes éligibles pour l'étude

Tout

La description

Inclusion Criteria:

  1. All participants

    • 18-35 years of age
    • Scoring less than or equal to 8 on the Hamilton Rating Scale for Depression (HRSD) at screen visit
  2. Participants with Bipolar Disorder (BD)

    • Diagnosis of Bipolar Disorder I/II (BDI/II) (DSM-5 criteria) in remission (euthymic for >2 months) or with mild-moderate hypomania
    • <15 on the Young Mania Rating Scale
    • Not psychotic
    • <3 on delusions, hallucinations, unusual thought content, and conceptual disorganization items of the Positive and Negative Syndrome Scale (PANSS)
    • Unmedicated or on any combination (except antidepressant monotherapy) of anxiolytics (benzodiazepines, buspirone, pregabalin, hydroxyzine) as needed, and/or atypical antipsychotics, and/or lithium, and/or other mood stabilizers, and/or non-SNRI antidepressants and/or non benzodiazepine hypnotics, as these are commonly-prescribed medications for BD
  3. Participants without Bipolar Disorder

    • No present or lifetime history of BD or psychiatric disorder other than anxiety or non BD mood disorders
    • Not in a current depressive episode
    • No family history of BD

Exclusion Criteria:

  1. All participants

    • History of head injury, neurological, pervasive developmental disorder (e.g. autism), systemic medical disease and treatment (medical records, participant report)

    • Family history of epilepsy (TBS exclusion criterion)

    • Use of substances with seizure risk (e.g., stimulants) in the past month, assessed as at screening, baseline, and before each fMRI-cTBS-fMRI session

    • Mini-Mental State Examination score (cognitive state) <24

    • Premorbid National Adult Reading Test Intelligent Quotient estimate<85

    • Visual disturbance: <20/40 Snellen visual acuity

    • Left/mixed handedness

    • History of alcohol/substance use disorder (SUD; all substances, including nicotine), and/or illicit substance use (except cannabis) over the last 6 months (SCID-5). Note: lifetime/present cannabis use (at non-abuse (<3 times in the past month) and non SUD levels) will be allowed, given its common usage in BD and young adults. Cannabis SUD over the last 6 months will not be allowed. Urine tests on scan days will exclude current illicit substance use (except cannabis). Salivary alcohol tests on scan days will exclude intoxicated individuals

    • Binge drinking in the week before, and/or >3 units/day for the 3 days before, and/or alcohol in the last 12 hrs before, any cTBS scan day, confirmed at screening and scan days (to avoid TBS during alcohol withdrawal). Alcohol/nicotine/ caffeine/cannabis use (below SCID-5 SUD, binge levels) will be allowed, and used as covariates

    • MRI exclusion criteria: metallic objects, e.g., surgical implants; claustrophobia; proneness; positive pregnancy test for females (performed at the MRRC) or self-report pregnancy

    • Inability to understand English

    • <18 years of age or >35 year of age

      • SNRI antidepressants and bupropion will not be allowed, as they can elevate seizure risk, a contraindication for TBS
      • Scoring greater than or equal to 8 on HRSD and in depressive episode is confirmed on SCID-5 at screen visit
      • Scoring greater than or equal to 18 on HRSD at any visit
      • In current depressive episode
  2. Participants with Bipolar Disorder

    • BD diagnosis other than BDI/II
    • More severe hypo/mania (YMRS>15)
    • Psychosis
    • Using psychotropic medications other than those allowed in inclusion criteria
  3. Participants without Bipolar Disorder

    • Present/ lifetime history of any psychiatric disorder other than anxiety and non BD mood disorders
    • Family history of of BD

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Science basique
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation croisée
  • Masquage: Quadruple

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: Left ventrolateral prefrontal cortex (vlPFC)/Left SS/Left vlPFC sham

A random number sequence will be generated for randomization of the 3 cTBS scan session order to which each participant is assigned:

  • left vlPFC cTBS (cTBS applied to the left ventrolateral prefrontal cortex)
  • left SS cTBS (cTBS applied to the left somatosensory area)
  • left vlPFC sham TBS (go through the motions of applying cTBS to the left ventrolateral prefrontal cortex but very low current is administered so that the participant feels like cTBS is being administered even though the current is too low to stimulate brain cells) Participants will know that one session will be a sham, but they will be blinded to which session is the sham.

cTBS is a brief stimulation of a part of the brain with a magnetic field that passes through the scalp and skull safely. It is FDA-approved as a treatment for psychological conditions including depression; however, this device is not approved for the treatment of adults with Bipolar Disorder I or for use in healthy adults. This research study is using the cTBS off label in all participants (those with and without Bipolar Disorder I) to examine research questions

Autres noms:
  • Stimulation magnétique transcrânienne (TMS)

Sham cTBS goes through the motions of applying cTBS to the brain but administers very low current so that the participant feels like cTBS is being administered even though the current is too low to stimulate brain cells. Participants will know that one session will be a sham, but they will be blinded to which session is the sham

Autres noms:
  • Stimulation magnétique transcrânienne factice (Sham TMS)
Expérimental: Left vlPFC/Left vlPFC sham/Left SS

A random number sequence will be generated for randomization of the 3 cTBS scan session order to which each participant is assigned:

  • left vlPFC cTBS (cTBS applied to the left ventrolateral prefrontal cortex)
  • left SS cTBS (cTBS applied to the left somatosensory area)
  • left vlPFC sham TBS (go through the motions of applying cTBS to the left ventrolateral prefrontal cortex but very low current is administered so that the participant feels like cTBS is being administered even though the current is too low to stimulate brain cells) Participants will know that one session will be a sham, but they will be blinded to which session is the sham.

cTBS is a brief stimulation of a part of the brain with a magnetic field that passes through the scalp and skull safely. It is FDA-approved as a treatment for psychological conditions including depression; however, this device is not approved for the treatment of adults with Bipolar Disorder I or for use in healthy adults. This research study is using the cTBS off label in all participants (those with and without Bipolar Disorder I) to examine research questions

Autres noms:
  • Stimulation magnétique transcrânienne (TMS)

Sham cTBS goes through the motions of applying cTBS to the brain but administers very low current so that the participant feels like cTBS is being administered even though the current is too low to stimulate brain cells. Participants will know that one session will be a sham, but they will be blinded to which session is the sham

Autres noms:
  • Stimulation magnétique transcrânienne factice (Sham TMS)
Expérimental: Left SS/Left vlPFC sham/Left vlPFC

A random number sequence will be generated for randomization of the 3 cTBS scan session order to which each participant is assigned:

  • left vlPFC cTBS (cTBS applied to the left ventrolateral prefrontal cortex)
  • left SS cTBS (cTBS applied to the left somatosensory area)
  • left vlPFC sham TBS (go through the motions of applying cTBS to the left ventrolateral prefrontal cortex but very low current is administered so that the participant feels like cTBS is being administered even though the current is too low to stimulate brain cells) Participants will know that one session will be a sham, but they will be blinded to which session is the sham.

cTBS is a brief stimulation of a part of the brain with a magnetic field that passes through the scalp and skull safely. It is FDA-approved as a treatment for psychological conditions including depression; however, this device is not approved for the treatment of adults with Bipolar Disorder I or for use in healthy adults. This research study is using the cTBS off label in all participants (those with and without Bipolar Disorder I) to examine research questions

Autres noms:
  • Stimulation magnétique transcrânienne (TMS)

Sham cTBS goes through the motions of applying cTBS to the brain but administers very low current so that the participant feels like cTBS is being administered even though the current is too low to stimulate brain cells. Participants will know that one session will be a sham, but they will be blinded to which session is the sham

Autres noms:
  • Stimulation magnétique transcrânienne factice (Sham TMS)
Expérimental: Left SS/Left vlPFC/Left vlPFC sham

A random number sequence will be generated for randomization of the 3 cTBS scan session order to which each participant is assigned:

  • left vlPFC cTBS (cTBS applied to the left ventrolateral prefrontal cortex)
  • left SS cTBS (cTBS applied to the left somatosensory area)
  • left vlPFC sham TBS (go through the motions of applying cTBS to the left ventrolateral prefrontal cortex but very low current is administered so that the participant feels like cTBS is being administered even though the current is too low to stimulate brain cells) Participants will know that one session will be a sham, but they will be blinded to which session is the sham.

cTBS is a brief stimulation of a part of the brain with a magnetic field that passes through the scalp and skull safely. It is FDA-approved as a treatment for psychological conditions including depression; however, this device is not approved for the treatment of adults with Bipolar Disorder I or for use in healthy adults. This research study is using the cTBS off label in all participants (those with and without Bipolar Disorder I) to examine research questions

Autres noms:
  • Stimulation magnétique transcrânienne (TMS)

Sham cTBS goes through the motions of applying cTBS to the brain but administers very low current so that the participant feels like cTBS is being administered even though the current is too low to stimulate brain cells. Participants will know that one session will be a sham, but they will be blinded to which session is the sham

Autres noms:
  • Stimulation magnétique transcrânienne factice (Sham TMS)
Expérimental: Left vlPFC sham/Left SS/Left vlPFC

A random number sequence will be generated for randomization of the 3 cTBS scan session order to which each participant is assigned:

  • left vlPFC cTBS (cTBS applied to the left ventrolateral prefrontal cortex)
  • left SS cTBS (cTBS applied to the left somatosensory area)
  • left vlPFC sham TBS (go through the motions of applying cTBS to the left ventrolateral prefrontal cortex but very low current is administered so that the participant feels like cTBS is being administered even though the current is too low to stimulate brain cells) Participants will know that one session will be a sham, but they will be blinded to which session is the sham.

cTBS is a brief stimulation of a part of the brain with a magnetic field that passes through the scalp and skull safely. It is FDA-approved as a treatment for psychological conditions including depression; however, this device is not approved for the treatment of adults with Bipolar Disorder I or for use in healthy adults. This research study is using the cTBS off label in all participants (those with and without Bipolar Disorder I) to examine research questions

Autres noms:
  • Stimulation magnétique transcrânienne (TMS)

Sham cTBS goes through the motions of applying cTBS to the brain but administers very low current so that the participant feels like cTBS is being administered even though the current is too low to stimulate brain cells. Participants will know that one session will be a sham, but they will be blinded to which session is the sham

Autres noms:
  • Stimulation magnétique transcrânienne factice (Sham TMS)
Expérimental: Left vlPFC sham/Left vlPFC/Left SS

A random number sequence will be generated for randomization of the 3 cTBS scan session order to which each participant is assigned:

  • left vlPFC cTBS (cTBS applied to the left ventrolateral prefrontal cortex)
  • left SS cTBS (cTBS applied to the left somatosensory area)
  • left vlPFC sham TBS (go through the motions of applying cTBS to the left ventrolateral prefrontal cortex but very low current is administered so that the participant feels like cTBS is being administered even though the current is too low to stimulate brain cells) Participants will know that one session will be a sham, but they will be blinded to which session is the sham.

cTBS is a brief stimulation of a part of the brain with a magnetic field that passes through the scalp and skull safely. It is FDA-approved as a treatment for psychological conditions including depression; however, this device is not approved for the treatment of adults with Bipolar Disorder I or for use in healthy adults. This research study is using the cTBS off label in all participants (those with and without Bipolar Disorder I) to examine research questions

Autres noms:
  • Stimulation magnétique transcrânienne (TMS)

Sham cTBS goes through the motions of applying cTBS to the brain but administers very low current so that the participant feels like cTBS is being administered even though the current is too low to stimulate brain cells. Participants will know that one session will be a sham, but they will be blinded to which session is the sham

Autres noms:
  • Stimulation magnétique transcrânienne factice (Sham TMS)

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Reward expectancy-related left ventrolateral prefrontal cortex activity
Délai: Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)

The difference in magnitude between pre and post cTBS scans for each cTBS condition of the extracted blood oxygen level-dependent (BOLD) signal from the left ventrolateral prefrontal cortex to the uncertain reward expectancy regressor during performance of the reward task

Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)
Reward expectancy-related right ventrolateral prefrontal cortex activity
Délai: Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)

The difference in magnitude between pre and post cTBS scans for each cTBS condition of the extracted BOLD signal from the right ventrolateral prefrontal cortex to the uncertain reward expectancy regressor during performance of the reward task

Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)
Reward expectancy-related left ventral striatum activity
Délai: Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)

The difference in magnitude between pre and post cTBS scans for each cTBS condition of the extracted BOLD signal from the left ventral striatum to the uncertain reward expectancy regressor during performance of the reward task

Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)
Reward expectancy-related right ventral striatum activity
Délai: Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)

The difference in magnitude between pre and post cTBS scans for each cTBS condition of the extracted BOLD signal from the left ventral striatum to the uncertain reward expectancy regressor during performance of the reward task

Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)
Reward expectancy-related left orbitofrontal cortex activity
Délai: Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)

The difference in magnitude between pre and post cTBS scans for each cTBS condition of the extracted BOLD signal from the left orbitofrontal cortex to the uncertain reward expectancy regressor during performance of the reward task

Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)
Reward expectancy-related right orbitofrontal cortex activity
Délai: Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)

The difference in magnitude between pre and post cTBS scans for each cTBS condition of the extracted BOLD signal from the left orbitofrontal cortex to the uncertain reward expectancy regressor during performance of the reward task

Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)
Reward expectancy-related midline rostral anterior cingulate cortex (rACC) activity
Délai: Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)

The difference in magnitude between pre and post cTBS scans for each cTBS condition of the extracted BOLD signal from the midline rostral anterior cingulate cortex (rACC) to the uncertain reward expectancy regressor during performance of the reward task

Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)
Reward expectancy-related midline dorsal anterior cingulate cortex activity
Délai: Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)

The difference in magnitude between pre and post cTBS scans for each cTBS condition of the extracted BOLD signal from the midline dorsal anterior cingulate cortex to the uncertain reward expectancy regressor during performance of the reward task

Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)
Reward expectancy-related left amygdala activity
Délai: Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)

The difference in magnitude between pre and post cTBS scans for each cTBS condition of the extracted BOLD signal from the left amygdala to the uncertain reward expectancy regressor during performance of the reward task

Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)
Reward expectancy-related right amygdala activity
Délai: Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)

The difference in magnitude between pre and post cTBS scans for each cTBS condition of the extracted BOLD signal from the left amygdala to the uncertain reward expectancy regressor during performance of the reward task

Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)
Reward expectancy-related left ventrolateral prefrontal cortex-right ventrolateral prefrontal cortex functional connectivity
Délai: Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)

The difference in magnitude between pre and post cTBS scans for each cTBS condition of the extracted parameter estimate for functional connectivity between the left and right ventrolateral prefrontal cortices to the uncertain reward expectancy regressor during performance of the reward task

Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)
Reward expectancy-related left ventrolateral prefrontal cortex-left ventral striatum functional connectivity
Délai: Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)

The difference in magnitude between pre and post cTBS scans for each cTBS condition of the extracted parameter estimate for functional connectivity between the left ventrolateral prefrontal cortex and left ventral striatum to the uncertain reward expectancy regressor during performance of the reward task

Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)
Reward expectancy-related left ventrolateral prefrontal cortex-right ventral striatum functional connectivity
Délai: Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)

The difference in magnitude between pre and post cTBS scans for each cTBS condition of the extracted parameter estimate for functional connectivity between the left ventrolateral prefrontal cortex and right ventral striatum to the uncertain reward expectancy regressor during performance of the reward task

Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)
Reward expectancy-related left ventrolateral prefrontal cortex-left orbitofrontal cortex functional connectivity
Délai: Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)

The difference in magnitude between pre and post cTBS scans for each cTBS condition of the extracted parameter estimate for functional connectivity between the left ventrolateral prefrontal cortex and left orbitofrontal cortex to the uncertain reward expectancy regressor during performance of the reward task

Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)
Reward expectancy-related left ventrolateral prefrontal cortex-right orbitofrontal cortex functional connectivity
Délai: Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)

The difference in magnitude between pre and post cTBS scans for each cTBS condition of the extracted parameter estimate for functional connectivity between the left ventrolateral prefrontal cortex and right orbitofrontal cortex to the uncertain reward expectancy regressor during performance of the reward task

Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)
Reward expectancy-related left ventrolateral prefrontal cortex-midline rostral anterior cingulate cortex functional connectivity
Délai: Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)

The difference in magnitude between pre and post cTBS scans for each cTBS condition of the extracted parameter estimate for functional connectivity between the left ventrolateral prefrontal cortex and midline rACC to the uncertain reward expectancy regressor during performance of the reward task

Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)
Reward expectancy-related left ventrolateral prefrontal cortex-midline dorsal anterior cingulate cortex functional connectivity
Délai: Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)

The difference in magnitude between pre and post cTBS scans for each cTBS condition of the extracted parameter estimate for functional connectivity between the left ventrolateral prefrontal cortex and midline dorsal anterior cingulate cortex to the uncertain reward expectancy regressor during performance of the reward task

Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)
Reward expectancy-related left ventrolateral prefrontal cortex-left amygdala functional connectivity
Délai: Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)

The difference in magnitude between pre and post cTBS scans for each cTBS condition of the extracted parameter estimate for functional connectivity between the left ventrolateral prefrontal cortex and left amygdala to the uncertain reward expectancy regressor during performance of the reward task

Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)
Reward expectancy-related left ventrolateral prefrontal cortex-right amygdala functional connectivity
Délai: Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)

The difference in magnitude between pre and post cTBS scans for each cTBS condition of the extracted parameter estimate for functional connectivity between the left ventrolateral prefrontal cortex and right amygdala to the uncertain reward expectancy regressor during performance of the reward task

Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Reward expectancy-related left ventrolateral prefrontal cortex wholebrain functional connectivity
Délai: Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)

The difference in magnitude between pre and post cTBS for each cTBS condition of the extracted parameter estimate for functional connectivity between the left ventrolateral prefrontal cortex and the whole brain to the uncertain reward expectancy regressor during performance of the reward task

Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)
Left ventrolateral prefrontal cortex activity
Délai: Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)

The difference in magnitude between pre and post cTBS scans for each cTBS condition of the extracted BOLD signal in the left ventrolateral prefrontal cortex to the contrast of possible win vs. neutral control conditions

Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)
Right ventrolateral prefrontal cortex activity
Délai: Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)

The difference in magnitude between pre and post cTBS scans for each cTBS condition of the extracted BOLD signal in the right ventrolateral prefrontal cortex to the contrast of possible win vs. neutral control conditions

Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)
Left ventral striatum activity
Délai: Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)

The difference in magnitude between pre and post cTBS scans for each cTBS condition of the extracted BOLD signal in the left ventral striatum to the contrast of possible win vs. neutral control conditions

Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)
Right ventral striatum activity
Délai: Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)

The difference in magnitude between pre and post cTBS scans for each cTBS condition of the extracted BOLD signal in the right ventral striatum to the contrast of possible win vs. neutral control conditions

Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)
Left orbitofrontal cortex activity
Délai: Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)

The difference in magnitude between pre and post cTBS scans for each cTBS condition of the extracted BOLD signal in the left orbitofrontal cortex to the contrast of possible win vs. neutral control conditions

Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)
Right orbitofrontal cortex activity
Délai: Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)

The difference in magnitude between pre and post cTBS scans for each cTBS condition of the extracted BOLD signal in the right orbitofrontal cortex to the contrast of possible win vs. neutral control conditions

Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)
Midline rostral anterior cingulate cortex activity
Délai: Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)

The difference in magnitude between pre and post cTBS scans for each cTBS condition of the extracted BOLD signal in the midline rostral anterior cingulate cortex to the contrast of possible win vs. neutral control conditions

Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)
Midline dorsal anterior cingulate cortex activity
Délai: Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)

The difference in magnitude between pre and post cTBS scans for each cTBS condition of the extracted BOLD signal in the midline dorsal anterior cingulate cortex to the contrast of possible win vs. neutral control conditions

Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)
Left amygdala activity
Délai: Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)

The difference in magnitude between pre and post cTBS scans for each cTBS condition of the extracted BOLD signal in the left amygdala to the contrast of possible win vs. neutral control conditions

Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)
Right amygdala activity
Délai: Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)

The difference in magnitude between pre and post cTBS scans for each cTBS condition of the extracted BOLD signal in the right amygdala to the contrast of possible win vs. neutral control conditions

Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)
Left ventral lateral prefrontal cortex-wholebrain functional connectivity
Délai: Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)

The difference in magnitude between pre and post cTBS scans for each cTBS condition of the extracted parameter estimates of functional connectivity between the left ventrolateral prefrontal cortex and the wholebrain to the contrast of possible win vs. neutral control conditions

Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)
Prediction error-related left ventral striatum activity
Délai: Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)

The difference in magnitude between pre and post cTBS scans for each cTBS condition of the extracted BOLD signal in the left ventral striatum to the prediction error regressor

Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)
Prediction error-related right ventral striatum activity
Délai: Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)

The difference in magnitude between pre and post cTBS scans for each cTBS condition of the extracted BOLD signal in the right ventral striatum to the prediction error regressor

Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)
Prediction error-related left ventral striatum-wholebrain functional connectivity
Délai: Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)

The difference in magnitude between pre and post cTBS scans for each cTBS condition of the extracted parameter estimates of resting state functional connectivity between the left ventral striatum and the wholebrian to the prediction error regressor

Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)
Prediction error-related right ventral striatum-wholebrain functional connectivity
Délai: Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)

The difference in magnitude between pre and post cTBS scans for each cTBS condition of the extracted parameter estimates of resting state functional connectivity between the right ventral striatum and the wholebrain

Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)

Autres mesures de résultats

Mesure des résultats
Description de la mesure
Délai
Left ventrolateral prefrontal cortex-wholebrain resting state functional connectivity
Délai: Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)

The difference in magnitude between pre and post cTBS scans for each cTBS condition of the extracted parameter estimates of resting state functional connectivity between the left ventrolateral prefrontal cortex and the wholebrain

Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)
Left ventrolateral prefrontal cortex-right ventrolateral prefrontal cortex resting state functional connectivity
Délai: Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)

The difference in magnitude between pre and post cTBS scans for each cTBS condition of the extracted parameter estimates of resting state functional connectivity between the left and right ventrolateral prefrontal cortices

Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)
Left ventrolateral prefrontal cortex-left ventral striatum resting state functional connectivity
Délai: Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)

The difference in magnitude between pre and post cTBS scans for each cTBS condition of the extracted parameter estimates of resting state functional connectivity between the left ventrolateral prefrontal cortex and the left ventral striatum

Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)
Left ventrolateral prefrontal cortex-right ventral striatum resting state functional connectivity
Délai: Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)

The difference in magnitude between pre and post cTBS scans for each cTBS condition of the extracted parameter estimates of resting state functional connectivity between the left ventrolateral prefrontal cortex and the right ventral striatum

Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)
Left ventrolateral prefrontal cortex-left orbitofrontal cortex resting state functional connectivity
Délai: Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)

The difference in magnitude between pre and post cTBS scans for each cTBS condition of the extracted parameter estimates of resting state functional connectivity between the left ventrolateral prefrontal cortex and the left orbitofrontal cortex

Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)
Left ventrolateral prefrontal cortex-right orbitofrontal cortex resting state functional connectivity
Délai: Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)

The difference in magnitude between pre and post cTBS scans for each cTBS condition of the extracted parameter estimates of resting state functional connectivity between the left ventrolateral prefrontal cortex and the right orbitofrontal cortex

Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)
Left ventrolateral prefrontal cortex-midline rostral anterior cingulate cortex resting state functional connectivity
Délai: Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)

The difference in magnitude between pre and post cTBS scans for each cTBS condition of the extracted parameter estimates of resting state functional connectivity between the left ventrolateral prefrontal cortex and the midline rostral anterior cingulate cortex

Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)
Left ventrolateral prefrontal cortex-midline dorsal anterior cingulate cortex resting state functional connectivity
Délai: Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)

The difference in magnitude between pre and post cTBS scans for each cTBS condition of the extracted parameter estimates of resting state functional connectivity between the left ventrolateral prefrontal cortex and the midline dorsal anterior cingulate cortex

Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)
Left ventrolateral prefrontal cortex-left amygdala resting state functional connectivity
Délai: Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)

The difference in magnitude between pre and post cTBS scans for each cTBS condition of the extracted parameter estimates of resting state functional connectivity between the left ventrolateral prefrontal cortex and the left amygdala

Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)
Left ventrolateral prefrontal cortex-right amygdala resting state functional connectivity
Délai: Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)

The difference in magnitude between pre and post cTBS scans for each cTBS condition of the extracted parameter estimates of resting state functional connectivity between the left ventrolateral prefrontal cortex and the right amygdala

Change in magnitude immediately before and immediately after each cTBS condition at scan visits (30-60 mins)

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Parrainer

Collaborateurs

Les enquêteurs

  • Chercheur principal: Mary Phillips, MD, MD, University of Pittsburgh
  • Chercheur principal: Fabio Ferrarelli, MD, PhD, University of Pittsburgh

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

6 avril 2021

Achèvement primaire (Réel)

24 octobre 2025

Achèvement de l'étude (Réel)

24 octobre 2025

Dates d'inscription aux études

Première soumission

18 décembre 2020

Première soumission répondant aux critères de contrôle qualité

4 janvier 2021

Première publication (Réel)

6 janvier 2021

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

3 novembre 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

13 octobre 2026

Dernière vérification

1 octobre 2026

Plus d'information

Termes liés à cette étude

Autres numéros d'identification d'étude

  • STUDY20060322
  • R01MH122990 (Subvention/contrat des NIH des États-Unis)

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

OUI

Description du régime IPD

The investigators will complete and submit a National Data Archive (NDA) Data Sharing Agreement within 6 months of the Notice of Award Issue date. Study staff will upload data dictionary to the NDA website, and will review the NDA data definition for the measures collected and define the project's data definition harmonized to that standard. For measures not yet defined, project staff will work with the NDA staff to define the measure following NDA best practices. Informed consent will be collected from study participants that allows for broad sharing of participants' de-identified data. Study staff will use participants' personally identifiable information to generate NDA Global Unique Identifier (GUID) numbers for study participants.

All data will be identified by GUID numbers only prior to submission to the NDA database. Data transfer procedures will be in accordance with all Institutional Review Board guidelines and federal regulations including HIPAA.

Délai de partage IPD

Raw data and data from descriptive/raw measures will be submitted on a semi-annual basis by July 15 and January 15 or the next business day. We also agree to submit to NDA the analyzed data yielded in our project (i.e., 12 months after accomplishment of each primary aim or objective, or immediately upon publication of the project's primary results, whichever occurs first). The PIs reserve the right to publish on the stated aims in a timely manner during the period of the award. Data will be available for addressing other research questions (i.e. which are not described in funded/pending grants) as soon as the data have been checked for accuracy (a period which will be no later than one year after the completion of each assessment). After the award has ended, the study investigators will continue to test the stated aims, but will also continue to solicit collaborations with outside researchers and to consider data requests in a timely manner.

Critères d'accès au partage IPD

Outside investigators must submit a 1)proposal of the study aims, hypotheses, variables/constructs, analytic approach, and estimated duration of the proposed research; 2)resume, qualifications, source of financial support, and conflict of interest statement; 3)sign a data-sharing agreement and confidentiality statement that stipulates using the data for the stated research purposes only, securing the data using appropriate computer technology, not manipulating the data in order to identify participants, acknowledging the grant that supported data collection and management in publications/presentations, and destroying or returning the data after analyses are complete; 4)obtain approval from their Institutional Review Board, and along with other staff members who have access to the data, submit certificates of the University of Pittsburgh Education and Certification Program in Research Practice Fundamentals or provide written documentation pf similar human subjects protection training.

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Oui

produit fabriqué et exporté des États-Unis.

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .